Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.

— Days after retaining the Nickles Group, Novo Nordisk also hired Checkmate Government Relations, the new D.C. outpost of a ...

Research suggests potential health benefits beyond what popular diabetes and weight-loss drugs were first approved to treat.

You know Ozempic can help with weight loss, but how long can you stay on Ozempic exactly? Unfortunately, there isn’t a solid ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

With semaglutide shortages in the rearview, Novo Nordisk is doubling down on marketing efforts for its GLP-1 drugs.

The Maine Legislature is considering a bill that would require MaineCare to cover popular weight loss drugs like Ozempic. The ...

Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...

Acclaimed vocalist Michael Trotter Jr. of the husband-and-wife duo The War and Treaty, reveals his diabetes diagnosis in ...

Despite falling hard since last summer, shares of Novo Nordisk have more than doubled the market's overall performance. The ...